?

Less Ads, More News – YBH!
Saturday May 18th 2013
World News Map

FDA rebuff deals big blow to Novo Nordisk’s U.S. hopes

Share in an emailShare on FacebookShare on TwitterShare on Stumble UponShare on RedditShare on DiggSubscribe to Yes, But, However!Print this articleybh spacer

COPENHAGEN (Reuters) – U.S. regulators dealt a major blow to Novo Nordisk’s hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks.

Read More

article archive.

Post Published: 10 February 2013
Found in section: Finance